Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Human oral microbiome and its influence on mental health and brain disorders

Borrego-Ruiz A, Borrego JJ.

AIMS Microbiol. 2025 Apr 14;11(2):242-294. doi: 10.3934/microbiol.2025013. eCollection 2025.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

Chaperone-Mediated Autophagy: A Critical Regulator of Neuroinflammation and Neurodegeneration

Han YY, Huang XY, Su Y, Ma JJ, Wu J.

Adv Biol (Weinh). 2025 Oct;9(10):e00191. doi: 10.1002/adbi.202500191. Epub 2025 Jul 2.

A Head-to-Head Comparison of 18 F-FP-CIT and 18 F-FDOPA PET/CT in Early Parkinson Disease

Yoo SW, Ha S, Ryu DW, Oh Y, Kim JS.

Clin Nucl Med. 2025 Sep 1;50(9):809-816. doi: 10.1097/RLU.0000000000006024. Epub 2025 Jul 1.

Meta-analysis and in-silico functional characterization of the SNCA variant rs356220 in Parkinson's disease

Menon S, Rais N.

Sci Rep. 2025 Jul 2;15(1):23358. doi: 10.1038/s41598-025-04435-0.

Advances, challenges, and opportunities of human midbrain organoids for modelling of the dopaminergic system

Fiorenzano A, Sozzi E, Kastli R, Iazzetta MR, Bruzelius A, Arlotta P, Parmar M.

EMBO J. 2025 Aug;44(15):4181-4195. doi: 10.1038/s44318-025-00494-1. Epub 2025 Jul 2.

GBA1 Haplotypes and Age at Onset of Parkinson's Disease in the Asian Population

Li C, Ou R, Hou Y, Wei Q, Zhang L, Lin J, Chen X, Song W, Zhao B, Wu Y, Shang H.

Mov Disord. 2025 Sep;40(9):2012-2014. doi: 10.1002/mds.30283. Epub 2025 Jul 2.

Validation of Genome-Wide Association Study (GWAS)-Identified Risk Loci for Parkinson's Disease in the Chinese Population

Li C, Ou R, Hou Y, Wei Q, Zhang L, Lin J, Liu K, Huang J, Chen X, Song W, Zhao B, Wu Y, Shang H.

Mov Disord. 2025 Oct;40(10):2272-2274. doi: 10.1002/mds.30291. Epub 2025 Jul 3.

Treadmill training for gait rehabilitation in elderly patients with mild-to-moderate Parkinson's disease: a systematic review and meta-analysis

Yin X, Peng P, Zhang H, Hu J, Wei Y, Li P.

Front Neurol. 2025 Jun 18;16:1609912. doi: 10.3389/fneur.2025.1609912. eCollection 2025.

Sleep Disturbance in Parkinson's Disease: Consequences for the Brain and Disease Progression - A Narrative Review

Anderson KN, Keogh MJ, Gosse L.

Nat Sci Sleep. 2025 Jun 28;17:1521-1537. doi: 10.2147/NSS.S478860. eCollection 2025.

Soft Robotics for Parkinson's Disease Supported by Functional Materials and Artificial Intelligence

Mazumdar H, Khondakar KR, Das S, Kaushik A.

BME Front. 2025 Jul 2;6:0143. doi: 10.34133/bmef.0143. eCollection 2025.

Time to add two new disorders to neuropsychiatric aspects of Parkinson's disease

Sensi SL, De Rosa MA, Russo M, Thomas A, Onofrj M.

Clin Park Relat Disord. 2025 Jun 15;13:100358. doi: 10.1016/j.prdoa.2025.100358. eCollection 2025.

The effect of Gua Sha therapy on Parkinson's disease with rapid eye movement sleep behavior disorder: a randomized controlled trial

Chen M, Liu J, Ge H, Zhang X, Zhu Y, Ding Z, Chen J, Wang Q, Xu G.

Neurol Sci. 2025 Sep;46(9):4653-4662. doi: 10.1007/s10072-025-08335-z. Epub 2025 Jul 3.

Parkinson's disease: genetics and neuroinflammatory insights

Chandel I, Kumari S, Bagri K, Bhatia A, Deshmukh R.

Inflammopharmacology. 2025 Sep;33(9):4997-5009. doi: 10.1007/s10787-025-01832-9. Epub 2025 Jul 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias